You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma untreated with a BTK inhibitor [ID6493]
Awaiting development
Reference number:
GID-TA11639
Expected publication date: TBC
Project information
Project documents
35363-Pirtobrutinib-for-Mantle-Cell-Lymphoma-V1.0-JUL2024-NON-CONF.pdf (nihr.ac.uk)
Back to top